Literature DB >> 20405137

Late-onset ptosis and myopathy in a patient with a heterozygous insertion in POLG2.

Maggie C Walter1, Birgit Czermin, Solvig Muller-Ziermann, Stefanie Bulst, Joanna D Stewart, Gavin Hudson, Peter Schneiderat, Angela Abicht, Elke Holinski-Feder, Hanns Lochmüller, Patrick F Chinnery, Thomas Klopstock, Rita Horvath.   

Abstract

Polymerase gamma 1 (POLG) mutations are a frequent cause of both autosomal dominant and recessive complex neurological phenotypes. In contrast, only a single pathogenic mutation in one patient was reported in POLG2 so far. Here we describe a 62-year-old woman, carrying a novel heterozygous sequence variant in the POLG2 gene. She developed bilateral ptosis at 30 years of age, followed by exercise intolerance, muscle weakness and mild CK increase in her late forties. Muscle histology and respiratory chain activities were normal. Southern blot and long range PCR detected multiple mtDNA deletions, but no depletion in muscle DNA. Sequencing of POLG, PEO1, ANT1, OPA1 and RRM2B showed normal results. A novel heteroallelic 24 bp insertion (c.1207_1208ins24) was detected in POLG2. This 24 bp insertion into exon 7 causes missplicing and loss of exon 7 in myoblast cDNA. We did not detect POLG2 mutations in 62 patients with multiple mtDNA deletions in muscle DNA, suggesting that POLG2 mutations may represent a rare cause of autosomal dominant PEO.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20405137     DOI: 10.1007/s00415-010-5565-9

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  11 in total

1.  POLG mutations associated with Alpers' syndrome and mitochondrial DNA depletion.

Authors:  Robert K Naviaux; Khue V Nguyen
Journal:  Ann Neurol       Date:  2004-05       Impact factor: 10.422

2.  Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study.

Authors:  Petri Luoma; Atle Melberg; Juha O Rinne; Jyrki A Kaukonen; Nina N Nupponen; Richard M Chalmers; Anders Oldfors; Ilkka Rautakorpi; Leena Peltonen; Kari Majamaa; Hannu Somer; Anu Suomalainen
Journal:  Lancet       Date:  2004 Sep 4-10       Impact factor: 79.321

3.  Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene.

Authors:  Rita Horvath; Gavin Hudson; Gianfrancesco Ferrari; Nancy Fütterer; Sofia Ahola; Eleonora Lamantea; Holger Prokisch; Hanns Lochmüller; Robert McFarland; V Ramesh; Thomas Klopstock; Peter Freisinger; Fabrizio Salvi; Johannes A Mayr; Rene Santer; Marketa Tesarova; Jiri Zeman; Bjarne Udd; Robert W Taylor; Douglass Turnbull; Michael Hanna; Doreen Fialho; Anu Suomalainen; Massimo Zeviani; Patrick F Chinnery
Journal:  Brain       Date:  2006-04-18       Impact factor: 13.501

4.  Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions.

Authors:  G Van Goethem; B Dermaut; A Löfgren; J J Martin; C Van Broeckhoven
Journal:  Nat Genet       Date:  2001-07       Impact factor: 38.330

Review 5.  Inherited mitochondrial diseases of DNA replication.

Authors:  William C Copeland
Journal:  Annu Rev Med       Date:  2008       Impact factor: 13.739

6.  155th ENMC workshop: polymerase gamma and disorders of mitochondrial DNA synthesis, 21-23 September 2007, Naarden, The Netherlands.

Authors:  Patrick F Chinnery; Massimo Zeviani
Journal:  Neuromuscul Disord       Date:  2007-12-21       Impact factor: 4.296

7.  Mutant POLG2 disrupts DNA polymerase gamma subunits and causes progressive external ophthalmoplegia.

Authors:  Matthew J Longley; Susanna Clark; Cynthia Yu Wai Man; Gavin Hudson; Steve E Durham; Robert W Taylor; Simon Nightingale; Douglass M Turnbull; William C Copeland; Patrick F Chinnery
Journal:  Am J Hum Genet       Date:  2006-05-04       Impact factor: 11.025

8.  Genomic rearrangements in OPA1 are frequent in patients with autosomal dominant optic atrophy.

Authors:  N Fuhrmann; M V Alavi; P Bitoun; S Woernle; G Auburger; B Leo-Kottler; P Yu-Wai-Man; P Chinnery; B Wissinger
Journal:  J Med Genet       Date:  2009-02       Impact factor: 6.318

9.  Progressive external ophthalmoplegia and vision and hearing loss in a patient with mutations in POLG2 and OPA1.

Authors:  Silvio Ferraris; Susanna Clark; Emanuela Garelli; Guido Davidzon; Steven A Moore; Randy H Kardon; Rachelle J Bienstock; Matthew J Longley; Michelangelo Mancuso; Purificación Gutiérrez Ríos; Michio Hirano; William C Copeland; Salvatore DiMauro
Journal:  Arch Neurol       Date:  2008-01

10.  A mitochondrial encephalomyopathy: the first case with an established defect at the level of coenzyme Q.

Authors:  J C Fischer; W Ruitenbeek; F J Gabreëls; A J Janssen; W O Renier; R C Sengers; A M Stadhouders; H J ter Laak; J M Trijbels; J H Veerkamp
Journal:  Eur J Pediatr       Date:  1986-02       Impact factor: 3.183

View more
  24 in total

Review 1.  Genomics and genetics in the biology of adaptation to exercise.

Authors:  Claude Bouchard; Tuomo Rankinen; James A Timmons
Journal:  Compr Physiol       Date:  2011-07       Impact factor: 9.090

Review 2.  Mitochondrial disorders of DNA polymerase γ dysfunction: from anatomic to molecular pathology diagnosis.

Authors:  Linsheng Zhang; Sherine S L Chan; Daynna J Wolff
Journal:  Arch Pathol Lab Med       Date:  2011-07       Impact factor: 5.534

Review 3.  Defects of mitochondrial DNA replication.

Authors:  William C Copeland
Journal:  J Child Neurol       Date:  2014-06-30       Impact factor: 1.987

Review 4.  Mitochondrial genome maintenance in health and disease.

Authors:  William C Copeland; Matthew J Longley
Journal:  DNA Repair (Amst)       Date:  2014-04-26

Review 5.  Therapeutic Approaches to Treat Mitochondrial Diseases: "One-Size-Fits-All" and "Precision Medicine" Strategies.

Authors:  Emanuela Bottani; Costanza Lamperti; Alessandro Prigione; Valeria Tiranti; Nicola Persico; Dario Brunetti
Journal:  Pharmaceutics       Date:  2020-11-11       Impact factor: 6.321

Review 6.  Clinical and molecular features of POLG-related mitochondrial disease.

Authors:  Jeffrey D Stumpf; Russell P Saneto; William C Copeland
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-04-01       Impact factor: 10.005

7.  Yeast cells expressing the human mitochondrial DNA polymerase reveal correlations between polymerase fidelity and human disease progression.

Authors:  Yufeng Qian; Aashiq H Kachroo; Christopher M Yellman; Edward M Marcotte; Kenneth A Johnson
Journal:  J Biol Chem       Date:  2014-01-07       Impact factor: 5.157

8.  Whole exome sequencing identifies a homozygous POLG2 missense variant in an infant with fulminant hepatic failure and mitochondrial DNA depletion.

Authors:  Hemant Varma; Phyllis L Faust; Alejandro D Iglesias; Stephen M Lagana; Karen Wou; Michio Hirano; Salvatore DiMauro; Mahesh M Mansukani; Kirsten E Hoff; Peter L Nagy; William C Copeland; Ali B Naini
Journal:  Eur J Med Genet       Date:  2016-08-31       Impact factor: 2.708

Review 9.  Mitochondrial Diseases Part II: Mouse models of OXPHOS deficiencies caused by defects in regulatory factors and other components required for mitochondrial function.

Authors:  Luisa Iommarini; Susana Peralta; Alessandra Torraco; Francisca Diaz
Journal:  Mitochondrion       Date:  2015-01-29       Impact factor: 4.160

Review 10.  Human mitochondrial DNA replication machinery and disease.

Authors:  Matthew J Young; William C Copeland
Journal:  Curr Opin Genet Dev       Date:  2016-04-09       Impact factor: 5.578

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.